AERAMI THERAPEUTICS LOGO-VERTICAL- COLOR.png
Aerami Therapeutics to Present Data Supporting AER-901 Dosing Regimen at CHEST 2023
October 05, 2023 08:00 ET | Aerami Therapeutics Inc
DURHAM, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare...
Global Gene Delivery Technologies Market
Global Gene Delivery Technologies Markets, 2017-2022, 2022-2027F, 2032F: Mapping the Genetic Blueprint - The Role of Gene Delivery in Modern Medicine
October 02, 2023 05:23 ET | Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Gene Delivery Technologies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global gene delivery technologies...
AERAMI THERAPEUTICS LOGO-VERTICAL- COLOR.png
Aerami Therapeutics Announces Presentation of Phase 1 Clinical Trial Data for Lead Program AER-901 at the 2023 European Respiratory Society (ERS) International Congress
September 12, 2023 09:48 ET | Aerami Therapeutics Inc
DURHAM, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare...
ReportLinker logo.jpg
Gene Delivery Technologies Global Market Report 2023
August 24, 2023 13:55 ET | ReportLinker
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gene Delivery Technologies Global Market Report 2023" -...
The Brainy Insights.png
Supply Chain Analytics Market to Reach USD 41.36 Billion by 2032; Rising Adoption of Big Data & Advanced Analytics Technologies to Propel Growth: The Brainy Insights
August 03, 2023 11:32 ET | The Brainy Insights
Newark, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the supply chain analytics market will grow to USD 7.97 billion in 2022 and reach USD 41.36 billion by 2032. In just ten...
SHELL PLC 2nd QUARTER 2023 AND HALF YEAR UNAUDITED RESULTS
July 27, 2023 02:00 ET | Shell plc
               SHELL PLC2nd QUARTER 2023 AND HALF YEAR UNAUDITED RESULTS                                SUMMARY OF UNAUDITED RESULTSQuarters$ million Half yearQ2 2023Q1 2023Q2...
Welcomes New Fellows Focused on Equity in Education and Public Safety
American Institutes for Research Welcomes New Fellows Focused on Equity in Education and Public Safety
July 12, 2023 10:00 ET | American Institutes for Research
Arlington, Va., July 12, 2023 (GLOBE NEWSWIRE) -- The American Institutes for Research (AIR) is welcoming two nationally renowned scholars as Institute Fellows who will bring their decades of...
Proficient Market Insights Final Logo-01-01.png
Global Trading of Carbon Credit Market (2023 to 2030) - Key Players Include South Pole Group, Aera Group, Terrapass, Green Mountain Energy
June 23, 2023 06:20 ET | Proficient Market Insights
PUNE, June 23, 2023 (GLOBE NEWSWIRE) -- "Trading of Carbon Credit Market" | End User (Personal, Enterprise), Types (Forestry, Renewable Energy, Landfill Methane Projects, Others), with United...
AERAMI THERAPEUTICS LOGO-VERTICAL- COLOR.png
Aerami Therapeutics Appoints Joshua Ziel as COO and Interim CEO and Expands Management Team as Lead Asset AER-901 (inhaled imatinib) Advances Toward Phase 2 in Pulmonary Hypertension
June 01, 2023 08:00 ET | Aerami Therapeutics Inc
Joshua Ziel, PhD, appointed as Chief Operating Officer and interim Chief Executive Officer Gary Burgess, MD, appointed as Chief Medical OfficerSarah Fritchley, PhD, appointed as Senior Vice President,...
AERAMI THERAPEUTICS LOGO-VERTICAL- COLOR.png
Aerami Therapeutics Announces Pharmacokinetic Data Demonstrating the Potential of AER-901 (Inhaled Imatinib) to Achieve Therapeutic Levels at Low Inhaled Doses for Treatment of Pulmonary Hypertension
May 24, 2023 08:58 ET | Aerami Therapeutics Inc
DURHAM, N.C., May 24, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare...